Abstract Noninvasive imaging in living subjects with positron emission tomography (PET) provides early detection of diseases in humans. For this application, it is necessary to prepare specific molecular imaging probes labeled with positron-emitting radioisotopes such as fluorine-18 for obtaining high-quality PET imaging. In this review, we describe recent trends in the F-18 radiolabeling method for the introduction of no-carrier-added fluorine-18, which was obtained from an 18 O(p,n) 18 F reaction, into a specific molecular site, which in turn is intended to serve as an imaging agent for PET study. These labeling protocols are based on ionic liquid media 18 F radiofluorination in the presence of some water, enzymatic 18 F fluorination using fluorinase in water solution, non-polar protic alcohol media 18 F radiofluorination and its mechanism, and nucleophilic 18 F fluorination of an aromatic iodonium salt precursor.
Introduction
Positron emission tomography (PET) has been widely used in the medical imaging of molecular and biological processes, and provides promising opportunities to monitor metabolism and detect diseases in humans [1] . It is necessary to prepare specific molecular imaging probes labeled with positron-emitting radioisotopes for obtaining high-quality PET imaging [1, 2] . For this application, in particular fluorine-18 has many desirable characteristics: 18 F-Radiolabeled biologically active compounds, such as peptides, neuro-transmitter ligands, and enzyme inhibitor analogues, can be used to trace biochemical processes while maintaining favorable interaction with the target since fluorine-18 can afford minimal steric interference; its relatively long half-life (t 1/2 =110 min) can allow [ 18 F ]-labeled radiopharmaceuticals to be produced regionally and shipped for imaging studies to nearby hospitals that are not equipped with cyclotrons for radionuclide production; the [ 18 F ]fluorine atom can form stable bonding to carbon at the molecular level; finally, fluorine-18 can be produced easily from cyclotron via irradiation of [ 18 O] water targets with proton beams [3] .
However, despite the many desirable characteristics of fluorine-18, only a few [ 18 F ]-radiolabeling processes are currently available for introducing fluorine-18 to biologically active compounds rapidly, efficiently, and conveniently [4] . In particular, in case of the preparation of receptor-binding PET radiopharmaceuticals, these processes require highly specific activity [5] . The typical method for introducing a single fluorine-18 at a specific molecular site is the nucleophilic displacement of the corresponding sulfonates and halides by the [ 18 F ]fluoride ion at the no-carrier-added level [4] [5] [6] [7] .
As shown in Fig. 1 [7] . In addition, because it is difficult to get a naked [ 18 
F]
fluoride anion that is completely anhydrous, naked hydroxide, which is generated from reaction media, leads to hydroxylations that form alcohols as a byproduct [7] . (Fig. 2a) . The reaction system was not capped for azeotropic removal of water to proceed simultaneously with the reaction at this reaction temperature, reducing the overall reaction time considerably. This means that [ [12] . Jeong et al. [14] F ]radiopharmaceutical was polar and contained many heteroatoms, because it became difficult to extract it from the ionic liquid phase [15] . To overcome this drawback of ionic liquids, there are some reports about a polymersupported ionic liquid that can be used for nucleophilic non-radioactive fluorination as a catalyst [15, 16] . However, the application of these catalysts to [ 18 F]-radiofluorination labeling reactions of radiopharmaceuticals has not been reported up to now.
Enzymatic [ 18 F] Radiofluorination Using Fluorinase Enzyme in Water Solution
Since fluorides are tightly hydrated and become "inert" fluorides ( Fig. 3) , water as a reaction medium cannot be used for nucleophilic fluorination [17] . Perhaps the sole exception to this is enzymatic fluorination in water catalyzed by a fluorinase enzyme, but here, specific hydrogen bonding of the enzyme with the fluoride and the substrate appears to facilitate the formation of C-F bonds [17, 18] . This finding that a fluorination enzyme as a biocatalyst (isolated from the bacterium Streptomyces cattleya) can provide C-F bond formation has opened up some prospects for such an [ 18 (Table 1) [23] . In this method, the tert-alcohol media, such as tert-butyl alcohol and tert-amyl alcohol, greatly enhanced the reactivity of alkali metal fluorides. In particular, the use of tert alcohols could reduce the formation of typical byproducts (namely, alkenes, alcohols, or ethers) dramatically in the nucleophilic fluorination of base-sensitive compounds, such as 1-(2-mesylethyl)naphthalene and N-5-bromopentanoyl-3,4-dimethoxyaniline (Table 1 , entries 2 and 3, respectively) compared with the use of conventional polar aprotic solvents [23] [24] [25] .
The attributes of this fluorination method play an important role in the efficient automatic preparation of [ 18 Because this finding was in marked contrast with the expectations from the conventional [
18 F]-radiofluorination mechanism; recently, the mechanism of the nucleophilic fluorination reaction in tert-alcohol solvent has been reported. As shown in Fig. 6 , the authors suggested the mechanism: limited solvation of [ 18 F] fluoride coordinated with bulky tert alcohols (named "flexible" fluoride) could make the fluoride an especially good nucleophile in this medium; leaving group reactivity could be enhanced by hydrogen bonding between the tert-alcohol solvent with oxygen atoms of a sulfonate leaving group; side reactions, such as eliminations, hydroxylations, and intramolecular alkylations, could be suppressed by the protic environment, particularly when using base-sensitive precursors [24, 25] . In a more recent paper, it was proven that "flexible" fluoride could be formed in the tert-alcohol media fluorination processing as a result of the preparation of tetrabutylammonium tetra t-butanol coordinated fluoride, TBAF(tBuOH) 4 , from commercially available TBAF in t-BuOH. This TBAF(t-BuOH) 4 also showed good performance in the nucleophilic fluorination because of its ideal favorable properties as a fluoride source, such as the dehydrated state for anhydrous reaction conditions, low hygroscopicity, good solubility in organic solvents, and good nucleophilicity with low basicity (Fig. 7 ) [29] [30] [31] . Fig. 7 This figure shows the reactivity of TBAF(t-BuOH) 4 and TBAF in a nucleophilic fluorination reaction (a) and X-ray crystal structure of "flexible" fluoride-TBAF(t-BuOH) 4 tion of 18 F on electron-deficient aromatic rings [33, 34] Fig. 8 [36, 37] . Ross et al. [38] developed heteroaromatic iodonium salts, such as aryl-(2-thienyl)iodonium salt derivatives, as precursors for regioselective nucleophilic [ 18 F] flurorination. In this report, the highly electron-rich heteroaromatic 2-thienyl group made the no-carrier-added [ 18 (Fig. 8c) . However, this [
Nucleophilic
18 F]-labeling method might often have the limitation of difficulty in preparing the iodonium salt precursor.
Conclusion
In summary, we have described various recent nucleophilic [ 18 F ]-radiolabeling protocols with no-carrier-added [ 18 F] fluoride. The final goal of these novel fluorine-18 radiolabeling protocols is to obtain F-18-labeled radiopharmaceuticals efficiently for their application as PET imaging agents in nuclear medicine and life sciences. This is a good example showing that, since it could become possible to produce [ 18 F ]-radiofluorination method, they could be used clinically and commercially in Korea. To increase the role of PET nuclear molecular imaging in medicine and life sciences, it is necessary to find both more reliable radiopharmaceuticals and radiolabeling methods. Many studies on the development of even more efficient protocols (greater selectivity, shorter reaction time, higher radiochemical yield, etc.) for nucleophilic radiolabeling reactions with no-carrier-added [ 18 F] fluoride to produce radiopharmaceuticals for in vivo imaging using PET are in progress in many research groups.
